Farmajes SRL
2.3 FTEFarmajes reported total assets of €1.28m at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jun 2026), with 2.3 full-time equivalents.
The score of Farmajes shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +14 % Total assets -6 % Headcount (avg FTE) +475 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farmajes's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
Farmajes's financial analysis
- Solvency6.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farmajes
Farmajes's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0681.788.254
- VAT number
- BE0681788254
- Peppol
- Registered · 0208:0681788254 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Sep 2017
- Registered office
- 2000 Antwerp
- Size
- Micro · 2.3 FTE
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Farmajes (SRL) has been based in Antwerp since 2017, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 4,035 € and equity of 85,951 €; its revenue is not published. With 2.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 6.7%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Farmajes
Companies in the same business, of comparable size and area, outside its group.
- Pharmakaisercentre Retail sale of pharmaceutical products Sprimont · balance sheet €1.28m
- Apotheek Paul Vanderhaegen Retail sale of pharmaceutical products Waregem · balance sheet €1.29m
- Pharmacie Dodrimont - Languenakers Retail sale of pharmaceutical products Juprelle · balance sheet €1.28m
- Pharmayou Waremme Gare Retail sale of pharmaceutical products Waremme · balance sheet €1.28m
- Bornem Pharma Retail sale of pharmaceutical products Bornem · balance sheet €1.27m
- Apoteek Van Elewyck - Sint Hubertus Retail sale of pharmaceutical products Hasselt · balance sheet €1.27m
- Pharma Hesbaye Retail sale of pharmaceutical products Liège · balance sheet €1.27m
- Officina Invest Retail sale of pharmaceutical products Aalst · balance sheet €1.30m
Frequently asked questions about Farmajes
What is the revenue of Farmajes?
Farmajes files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Farmajes?
In Belgium, the VAT number is the company number prefixed with BE: BE0681788254 for Farmajes, if the company is VAT-registered. Its company number (CBE) is 0681.788.254.
Where is the registered office of Farmajes?
According to the CBE register, the registered office of Farmajes is in 2000 Antwerp.
What is the equity of Farmajes?
At the close of the 2025 financial year, the equity of Farmajes amounts to 85,951 €, a solvency of 6.7% of total assets.
How many people work at Farmajes?
2.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Farmajes?
The register lists 2 active mandates at Farmajes. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Farmajes
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →